ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The authors thank the members of the SLCR at NIMH and the Johns Hopkins Biology Mouse Tri-Lab for helpful discussions. Funding sources: National Institute of Mental Health Grant <a href="" target="_blank"></a>&#160;<a href="" target="_blank"></a>ZIAMH002964 (S.H.)

All animal procedures were approved by and performed in accordance with the guidelines of the National Institute of Mental Health (NIMH) Animal Care and Use Committee (ASP-SLCR-01). All efforts were made to minimize pain and reduce the number of animals used. The research tools used are listed in the Table of Materials.
1. Chemogenetic strategy
<ol>
	<li>Intravitreal injection of adeno-associated virus in Opn4Cre/+ mice
	<ol>
		<li>Clean and sterilize the stereotaxic stage and all surgical instruments using appropriate sterilization procedures. Set up the injection apparatus and attach a glass capillary injection needle.</li>
		<li>Anesthetize the mouse using isoflurane. Set the oxygen flow rate to approximately 1.5 L/min. Adjust isoflurane to 3%&#8211;5% for induction and reduce to 1&#8211;3% for maintenance throughout the procedure.</li>
		<li>Verify adequate anesthesia using a toe pinch. Consider the animal fully anesthetized when no withdrawal or flinching reflex is observed.</li>
		<li>Place the mouse on a heating pad to maintain body temperature throughout the procedure.</li>
		<li>Pull glass capillary needles. Needles were marked at 2.0 mm from the tip using a fine marker under a stereomicroscope to ensure consistent penetration depth delivery.</li>
		<li>Gently apply pressure to the inferior eyelid with blunt-tipped forceps to slightly protrude the eyeball and expose the dorsal limbus. Using a dorsal approach, insert the needle tangentially to the surface of the eye and penetrate the sclera 0.5&#8211;1 mm posterior to the limbus while avoiding vascularized regions limbus. 
		NOTE: Ophthalmic ointment is not used during intravitreal injections in mice because it can contaminate or obstruct the injection needle, be inadvertently introduced into the vitreous cavity, causing tissue injury, and increase the risk of intraocular infection or inflammation.</li>
		<li>Insert the needle into the vitreous chamber to the predetermined depth. Withdraw slightly to relieve intraocular pressure and prevent blockage of the needle tip by tissue.</li>
		<li>Inject a total volume of 1.5 &#181;L AAV solution (at 2.4 x 1013 GC/ml), delivered as five sequential injections of 300 nL each (at the rate of 50nl/s). Pause for 10&#160;s between injections to allow diffusion and minimize reflux. After the final injection, wait 30 s before slowly withdrawing the needle. Repeat the same procedure in the contralateral eye using identical parameters, taking care to minimize trauma and reflux.</li>
		<li>Administer ketoprofen (10&#160;mg/kg, subcutaneously) immediately following surgery.</li>
		<li>Allow mice to recover for at least 2 weeks to ensure adequate viral expression before transferring them to the behavioral facility.</li>
	</ol>
	</li>
	<li>Wheel-running activity and CNO administration (Figure 1A)
	<ol>
		<li>House mice individually in cages equipped with running wheels. Record wheel-running activity using an automated data acquisition system.</li>
		<li>Entrained mice to a 12:12 h light&#8211;dark cycle for 4&#8211;7 days. Confirm stable entrainment and then transition animals to constant darkness (DD).</li>
		<li>Determine activity onset using analysis software. Define activity onset as CT12 in nocturnal rodents. Calculate CT4 accordingly.</li>
		<li>On day 8 in DD, mice receive intraperitoneal injections of CNO (1 mg/kg) or saline at CT4 under dim red light.</li>
		<li>Return animals to their home cages and maintain them under constant darkness. Record locomotor activity continuously for 8 days.</li>
		<li>Determine activity onsets and perform regression analysis on pre- and post-injection periods. Calculate phase shifts as the difference between projected and observed activity onset.</li>
	</ol>
	</li>
	<li>SCN c-Fos immunohistochemistry following chemogenetic activation
	<ol>
		<li>Entrained mice to a 12:12 h light&#8211;dark cycle and release into constant darkness. On the second day in DD, administer CNO at CT6. Perfuse animals 30 min after injection. 
		Note: CT4 was used in behavioral experiments to minimize the possibility of CNO effects extending into the subjective night, as CNO can remain active for several hours. In contrast, CT6 was used for immunostaining experiments to assess the acute effects of CNO on the circadian clock, with animals perfused 30 min after injection.</li>
		<li>Dissect the brain and post-fix in 4% paraformaldehyde overnight at 4 &#176;C. Cryoprotect in 30% sucrose until the tissue sinks. Section coronally at 40 &#181;m.</li>
		<li>Incubate sections in blocking solution, followed by primary antibody incubation overnight at 4 &#176;C. Wash and incubate with secondary antibodies for 1 h. Counterstain with DAPI and mount sections.</li>
		<li>Acquire images using consistent microscope settings. Process images using analysis software. Identify AAV-infected regions by mCherry-positive cells.</li>
	</ol>
	</li>
</ol>
2. Spectral strategy
<ol>
	<li>Transfer wild-type mice to the behavioral facility and house them individually in cages equipped with running wheels, as described above. Maintain animals under constant darkness (DD) to monitor free-running circadian activity.</li>
	<li>On day 8 in DD, at circadian time 6 (CT6), remove the cage from the light-tight cabinet and expose the mouse to a 15 min light pulse.</li>
	<li>Expose mice to either a blue light pulse (&#955;max = 470 nm; 1.8 &#215; 1014&#8211;2.2 &#215; 1014 photons/cm2/s) or a violet light pulse (&#955;max = 385 nm; 1.45 &#215; 1014&#8211;3.3 &#215; 1014 photons/cm2/s), with intensity measured at the center and all four corners of the cage at animal eye level.</li>
	<li>For both wavelength conditions, keep mice in their home cages with the cage tops removed. Position cages directly beneath a fixed light source such that the center of the light beam is aligned with the center of the cage to ensure uniform illumination.</li>
	<li>Immediately return cages to their original position under constant darkness following light exposure. Continue wheel-running activity recording uninterrupted for phase-shift analysis.</li>
</ol>

<ol>
	<li>Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295(5557):1065&#8211;70.</li>
	<li>Jones JR, Simon T, Lones L, Herzog ED. SCN VIP neurons are essential for normal light-mediated resetting of the circadian system. J Neurosci. 2018;38(37):7986&#8211;95.</li>
	<li>Coursey PJ. Daily light sensitivity rhythm in a rodent. Science. 1960;131:33&#8211;35.</li>
	<li>Kornhauser JM, Ginty DD, Greenberg ME, Mayo KE, Takahashi JS. Light entrainment and activation of signal transduction pathways in the SCN. Prog Brain Res. 1996;111:133&#8211;46.</li>
	<li>Ding JM, Weber ET, Faiman LE, Rea MA, Gillette MU. Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science. 1994;266(5191):1713.</li>
	<li>Mintz EM, Gillespie CF, Price KM, Albers HE. Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. J Neurosci. 1999;19(12):5124&#8211;30.</li>
	<li>Shirakawa T, Moore RY. Glutamate shifts the phase of the circadian neuronal firing rhythm in the rat suprachiasmatic nucleus in vitro. Neurosci Lett. 1994;178(1):47&#8211;50.</li>
	<li>Shibata S, Watanabe A, Hamada T, Ono M, Watanabe S. N-methyl-D-aspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro. Am J Physiol Regul Integr Comp Physiol. 1994;267(2):R360&#8211;R364.</li>
	<li>Asai M, Yamaguchi S, Isejima H, Jonouchi M, Moriya T, et al. Visualization of mPer1 transcription in vitro: NMDA induces a rapid phase shift of mPer1 gene in cultured SCN. Curr Biol. 2001;11(19):1524&#8211;27.</li>
	<li>Sladek M, Sumova A. Modulation of NMDA-mediated clock resetting in the suprachiasmatic nuclei of mPer2 (Luc) mouse by endocannabinoids. Front Physiol. 2019;10:361.</li>
	<li>Shibata S, Moore RY. Neuropeptide Y and optic chiasm stimulation affect suprachiasmatic nucleus circadian function in vitro. Brain Res. 1993;615(1):95&#8211;100.</li>
	<li>Jones JR, Tackenberg MC, McMahon DG. Manipulating circadian clock neuron firing rate resets molecular circadian rhythms and behavior. Nat Neurosci. 2015;18(3):373&#8211;75.</li>
	<li>Kim S, McMahon DG. Light sets the brain&#8217;s daily clock by regional quickening and slowing of the molecular clockworks at dawn and dusk. Elife. 2021;10:e70137.</li>
	<li>de Vries MJ, Treep JA, de Pauw ES, Meijer JH. The effects of electrical stimulation of the optic nerves and anterior optic chiasm on the circadian activity rhythm of the Syrian hamster: involvement of excitatory amino acids. Brain Res. 1994;642(1-2):206&#8211;12.</li>
	<li>Rusak B, Groos G. Suprachiasmatic stimulation phase shifts rodent circadian rhythms. Science. 1982;215(4538):1407&#8211;09.</li>
	<li>Duy PQ, Komal R, Richardson ME, Hahm KS, Fernandez DC, et al. Light has diverse spatiotemporal molecular changes in the mouse suprachiasmatic nucleus. J Biol Rhythms. 2020;35(6):576&#8211;87.</li>
	<li>Liu A, Milner ES, Peng YR, Blume HA, Brown MC, et al. Encoding of environmental illumination by primate melanopsin neurons. Science. 2023;379(6630):376&#8211;81.</li>
	<li>Milner ES, Do MTH. A population representation of absolute light intensity in the mammalian retina. Cell. 2017;171(4):865&#8211;876.e16.</li>
	<li>Komal R, Beier C, Nath A, et al. ipRGC properties prevent light from shifting the SCN clock during daytime. Nature. 2026;650(8103):942&#8211;50. .</li>
	<li>Jewett ME, Rimmer DW, Duffy JF, Klerman EB, Kronauer RE, et al. Human circadian pacemaker is sensitive to light throughout subjective day without evidence of transients. Am J Physiol Regul Integr Comp Physiol. 1997;273(5):R1800&#8211;R1809.</li>
	<li>Revell VL, Molina TA, Eastman CI. Human phase response curve to intermittent blue light using a commercially available device. J Physiol. 2012;590(19):4859&#8211;68.</li>
</ol>

The authors declare no competing interests.

The results demonstrate that activation of ipRGCs during the subjective day can induce circadian phase shifts in mice, a time typically characterized by reduced sensitivity to photic stimulation. A chemogenetic approach enabled selective activation of ipRGCs independent of external light and produced robust phase delays in wheel-running behavior. This activation also induced acute c-Fos expression in the SCN, confirming activation of the central circadian pacemaker. These findings indicate that strong ipRGC-driven stimul...

The suprachiasmatic nucleus (SCN), the master circadian clock of the mammalian brain, coordinates essential daily rhythms in physiology and behavior, including sleep&#8211;wake cycles and feeding patterns. To maintain alignment with the external environment, the SCN receives direct photic input from intrinsically photosensitive retinal ganglion cells (ipRGCs), which transmit retinal light information to synchronize internal circadian rhythms with the solar day1,2.
A defining feature of circadian systems across organisms is phase-dependent responsiveness: the same stimulus delivered at different circadian times can produce markedly different effects. In mammals, nocturnal light reliably induces phase shifts of the SCN clock, whereas exposure during the subjective day produces little or no resetting3,4. This apparent daytime insensitivity has been consistently observed in both in vivo and in vitro&#160;preparations, where attempts to mimic photic input fail to elicit significant phase shifts5,6,7,8,9,10,11,12,13,14,15,16.
Daytime insensitivity has been attributed, at least in part, to insufficient retinal drive to engage phase-resetting mechanisms, alongside circadian gating mechanisms within the SCN. Consistent with this idea, ipRGCs are not uniformly responsive under photopic conditions; a subset enters depolarization block, limiting sustained action potential firing17,18,19. This physiological constraint may reduce the effectiveness of conventional photic stimulation during the day. Overcoming this limitation would enable direct interrogation of daytime clock plasticity, a phase traditionally considered refractory to photic resetting.
Two complementary methodologies are described to enable robust phase shifting of the circadian clock during the subjective day. The first approach employs a chemogenetic strategy to selectively activate ipRGCs independent of ambient lighting conditions. Specifically, Opn4Cre/+ mice receive intravitreal injections of an adeno-associated virus (AAV) encoding the excitatory Designer Receptor Exclusively Activated by Designer Drugs (DREADD), hM3Dq, in a Cre-dependent manner. Administration of clozapine-N-oxide (CNO) at circadian time 4 (CT4) induces burst-like firing of ipRGCs, providing sustained activation of the retinohypothalamic pathway19. Phase shifts are quantified using locomotor activity recordings, and molecular activation within the SCN is assessed by c-Fos immunohistochemistry.
The second approach uses wavelength-specific optical stimulation as a non-invasive strategy for broader applicability. Wild-type mice are exposed to violet light (385 nm) at circadian time 6 (CT6), during the middle of the subjective day. Violet light produces reduced depolarization block and supports sustained ipRGC activation compared to blue or white light19. Phase shifts are quantified as described above.
Both approaches aim to enhance ipRGC-driven signaling to the SCN, thereby overcoming the reduced photic responsiveness characteristic of the subjective day. Together, these methodologies provide robust, experimentally tractable strategies for manipulating the circadian clock during a phase traditionally resistant to photic resetting.

<table><tbody><tr><td>AAV2-hSyn-DIO-hM3D(Gq)-mCherry</td><td>Addgene</td><td>44361</td><td>Cre-dependent viral vector encoding excitatory DREADD (hM3Dq) fused to mCherry for selective ipRGC activation</td></tr><tr><td>Anti-c-Fos antibody (rabbit monoclonal)</td><td>Cell Signaling Technology</td><td>2250S</td><td>Primary antibody used to detect c-Fos as a marker of neuronal activation</td></tr><tr><td>Anti-tdTomato antibody (goat)</td><td>LSBio</td><td>LS-C340696</td><td>Primary antibody used to detect mCherry/tdTomato reporter expression</td></tr><tr><td>Blue LED driver</td><td>Thorlabs</td><td>LEDD1B</td><td>Power supply for controlling intensity and output of blue LED</td></tr><tr><td>Blue LED light source</td><td>Thorlabs</td><td>M470L5</td><td>LED source emitting blue light (&amp;lambda;max &amp;asymp; 470 nm) for photic stimulation</td></tr><tr><td>ClockLab software</td><td>Actimetrics</td><td>Version 6.0.53</td><td>Software for acquisition and analysis of circadian locomotor activity data</td></tr><tr><td>Clozapine-N-oxide (CNO)</td><td>Sigma-Aldrich</td><td>C0832-5MG</td><td>Ligand used to activate hM3Dq DREADD receptors in vivo</td></tr><tr><td>DAPI</td><td>Invitrogen</td><td>62248</td><td>Fluorescent nuclear stain for labeling cell nuclei</td></tr><tr><td>Donkey anti-goat Alexa Fluor 555</td><td>Invitrogen</td><td>A21432</td><td>Fluorescent secondary antibody for detection of goat primary antibodies</td></tr><tr><td>Donkey anti-rabbit Alexa Fluor 488</td><td>Invitrogen</td><td>A21206</td><td>Fluorescent secondary antibody for detection of rabbit primary antibodies</td></tr><tr><td>Fluoromount-G</td><td>Invitrogen</td><td>00-4958-02</td><td>Mounting medium used to preserve fluorescence in tissue sections</td></tr><tr><td>ImageJ (Fiji) software</td><td>NIH</td><td>Version 2.16.0/1.54g</td><td>Open-source software for image processing and quantitative analysis</td></tr><tr><td>Opn4cre Mice</td><td>The Jackson Laboratry</td><td>RRID:IMSR_JAX:035925</td><td>Mice used for chemogenetic activation</td></tr><tr><td>Violet LED driver</td><td>Mightex</td><td>SLA-1000-2</td><td>Power supply for controlling violet LED output</td></tr><tr><td>Violet LED light source</td><td>Mightex</td><td>BLS-LCS-0385-04-22</td><td>LED source emitting violet light (&amp;lambda;max &amp;asymp; 385 nm) for wavelength-specific stimulation</td></tr><tr><td>Wild-type mice</td><td>The Jackson Laboratry</td><td>Jackson strain #101043</td><td>Mice used for violet light experiment</td></tr></tbody></table>

inducing daytime circadian phase shifts using chemogenetic and spectral approaches

Inducing Daytime Circadian Phase Shifts Using Chemogenetic and Spectral Approaches

In mammals, circadian phase shifting during the daytime is limited by reduced photic responsiveness of the suprachiasmatic nucleus (SCN), restricting the ability to experimentally manipulate the circadian clock during this phase. Reliable methods to induce daytime phase shifts are therefore essential for investigating mechanisms of circadian plasticity and photic entrainment. Complementary genetic and spectral strategies are described to enable robust, temporally precise manipulation of the circadian clock during the day. The first approach, currently limited to mice, employs a chemogenetic strategy involving intravitreal delivery of Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) to selectively activate intrinsically photosensitive retinal ganglion cells (ipRGCs). This approach permits controlled activation of the retinohypothalamic pathway and induces reproducible daytime phase shifts independent of ambient lighting conditions. The second approach utilizes wavelength-specific optical stimulation as a non-invasive alternative. Exposure to violet light exploits the spectral sensitivity of ipRGCs to reduce depolarization block and promote sustained activation, enabling reliable phase resetting during the subjective day. This method is broadly applicable across mammalian systems and does not require genetic manipulation or pharmacological intervention. Detailed protocols are provided for experimental preparation, stimulation timing, validation of phase shifts using locomotor activity, and assessment of neuronal activation via c-Fos immunohistochemistry. Key considerations, including circadian timing, stimulus parameters, and experimental controls, are outlined to facilitate reproducibility. Together, these approaches provide versatile and experimentally tractable tools for inducing daytime circadian phase shifts and enable direct investigation of mechanisms underlying daytime circadian responsiveness.

Opn4Cre/+ mice expressing AAV-DREADD that received saline at CT4 did not exhibit a significant phase shift in wheel-running activity (n = 5; Figure 1B). In contrast, CNO administration at CT4 produced a significant phase delay in activity onset (mean ± SEM: 5.03 ± 0.48 h; n = 5; Figure 1C, D), demonstrating that DREADD activation at this circadian time shifts locomotor activity rhythms. A schematic of the experimental design is shown ...

This study introduces chemogenetic and violet light&#8211;based strategies to enable reliable daytime circadian phase shifting.

In mammals, circadian phase shifting during the daytime is limited by reduced photic responsiveness of the suprachiasmatic nucleus (SCN), restricting the ...

inducing-daytime-circadian-phase-shifts-using-chemogenetic-spectral

Research

JoVE Journal

Neuroscience

This article will review methods that can be used to determine circadian function and light responsiveness in mice.

Measuring Circadian and Acute Light Responses in Mice using Wheel Running Activity

Circadian clocks function within individual cells, i.e., they are cell-autonomous. Here, we describe methods for generating cell-autonomous clock models using non-invasive, luciferase-based real-time bioluminescence technology. Reporter cells provide tractable, functional model systems for studying circadian biology.

Monitoring Cell-autonomous Circadian Clock Rhythms of Gene Expression Using Luciferase Bioluminescence Reporters

Source: Kodani, S., et.al. Optogenetic Manipulation of Neural Circuits During Monitoring Sleep/wakefulness States in Mice. J. Vis. Exp. (2019)This video demonstrates the optogenetic manipulation of neural circuits involved in the sleep-to-wakefulness transition in mice. The procedure involves surgically implanting an optic fiber and electrodes into the brain and muscles to enable light stimulation and electrophysiological recording. By delivering light to activate light-sensitive cation...

Optogenetic Manipulation of Neural Circuits for the Sleep-to-Wakefulness Transition in Mice

An in vitro bioluminescence assay to determine cellular circadian rhythm in mammary epithelial cells is presented. This method utilizes mammalian cell reporter plasmids expressing destabilized luciferase under the control of the PERIOD 2 gene promoter. It can be adapted to other cell types to evaluate organ-specific effects on circadian rhythm.

In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells

Genetically encoded luciferase is a popular non-invasive reporter of gene expression. Use of an automated longitudinal luciferase imaging gas- and temperature-optimized recorder (ALLIGATOR) enables longitudinal recording from bioluminescent cells under a wide range of conditions. Here we show how ALLIGATOR may be used in the context of circadian rhythms research.

Flexible Measurement of Bioluminescent Reporters Using an Automated Longitudinal Luciferase Imaging Gas- and Temperature-optimized Recorder (ALLIGATOR)

This newly developed fluorescence-based technology enables long-term monitoring of the transcription of circadian clock genes in the suprachiasmatic nucleus (SCN) of freely moving mice in real-time and at a high temporal resolution.

In Vivo Monitoring of Circadian Clock Gene Expression in the Mouse Suprachiasmatic Nucleus Using Fluorescence Reporters

Here, we present a method to investigate diurnal rhythms in performance following accurate categorization of participants into circadian phenotype groups based on the Munich ChronoType Questionnaire, gold standard circadian phase biomarkers and actigraphic measures.

Human Circadian Phenotyping and Diurnal Performance Testing in the Real World

Here, we detail how to synchronize Drosophila to a circadian day. This is the first, and most important step necessary for studying biological rhythms and chronobiology.

Circadian Entrainment of Drosophila Melanogaster

We describe procedures for recording daily locomotor activity rhythms of Drosophila and subsequent data analysis. Locomotor activity rhythms are a reliable behavioral output of animal circadian clocks and are used as the standard readout of clock function when studying circadian mutants or examining how the environment regulates the circadian system.

Assaying Locomotor Activity to Study Circadian Rhythms and Sleep Parameters in Drosophila

RNA expression profiling of discrete mouse brain regions requires a precise and repeatable tissue collection strategy.  A protocol that uses both coronal brain sectioning and tissue corer-assisted microdissection is described here.  The yield and quality of total RNA obtained from the resulting samples confirms the utility of the outlined method.

Non-Laser Capture Microscopy Approach for the Microdissection of Discrete Mouse Brain Regions for Total RNA Isolation and Downstream Next-Generation Sequencing and Gene Expression Profiling

National Institute of Mental Health (NIMH), National Institutes of Health (NIH).  This study introduces chemogenetic and violet light–based strategies to enable reliable daytime circadian phase shifting.

Inducing Daytime Circadian Phase Shifts Using Chemogenetic and Spectral Approaches

Explore More Videos